BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12903845)

  • 1. Tamoxifen's impact as a preventive agent in clinical practice and an update on the STAR trial.
    Wickerham DL
    Recent Results Cancer Res; 2003; 163():87-95; discussion 264-6. PubMed ID: 12903845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer prevention: results of the National Surgical Adjuvant Breast and Bowel Project (NSABP) breast cancer prevention trial (NSABP P-1: BCPT).
    Dunn BK; Ford LG
    Eur J Cancer; 2000 Sep; 36 Suppl 4():S49-50. PubMed ID: 11056316
    [No Abstract]   [Full Text] [Related]  

  • 3. Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts.
    Vogel VG
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4413s-4418s; discussion 4411s-4412s. PubMed ID: 11916233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Breast Cancer Prevention Trial: evaluating tamoxifen's efficacy in preventing breast cancer.
    McKeon VA
    J Obstet Gynecol Neonatal Nurs; 1997; 26(1):79-90. PubMed ID: 9017550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ.
    Vogel VG; Costantino JP; Wickerham DL; Cronin WM
    Clin Cancer Res; 2003 Jan; 9(1 Pt 2):495S-501S. PubMed ID: 12538506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen--an update on current data and where it can now be used.
    Wickerham L
    Breast Cancer Res Treat; 2002 Oct; 75 Suppl 1():S7-12; discussion S33-5. PubMed ID: 12353826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of tamoxifen's efficacy for preventing the formation and growth of breast tumors.
    Radmacher MD; Simon R
    J Natl Cancer Inst; 2000 Jan; 92(1):48-53. PubMed ID: 10620633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost effectiveness of tamoxifen in the prevention of breast cancer.
    Noe LL; Becker RV; Gradishar WJ; Gore M; Trotter JP
    Am J Manag Care; 1999 Jun; 5(6 Suppl):S389-406. PubMed ID: 10538851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.
    Jahanzeb M
    Clin Ther; 2007 Aug; 29(8):1535-47. PubMed ID: 17919537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen's role in chemoprevention of breast cancer: an update.
    Nayfield SG
    J Cell Biochem Suppl; 1995; 22():42-50. PubMed ID: 8538209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the effect of tamoxifen chemoprevention on long-term mortality in white women at high risk of breast cancer.
    Maucort-Boulch D; Roy P
    Eur J Cancer Prev; 2006 Aug; 15(4):347-52. PubMed ID: 16835505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
    Vogel VG; Costantino JP; Wickerham DL; Cronin WM
    J Natl Cancer Inst; 2002 Oct; 94(19):1504. PubMed ID: 12359860
    [No Abstract]   [Full Text] [Related]  

  • 13. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.
    King MC; Wieand S; Hale K; Lee M; Walsh T; Owens K; Tait J; Ford L; Dunn BK; Costantino J; Wickerham L; Wolmark N; Fisher B;
    JAMA; 2001 Nov; 286(18):2251-6. PubMed ID: 11710890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of hormone-related cancers: breast cancer.
    Dunn BK; Wickerham DL; Ford LG
    J Clin Oncol; 2005 Jan; 23(2):357-67. PubMed ID: 15637398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen and breast cancer--from palliation to prevention.
    Rich SE
    Cancer Nurs; 1993 Oct; 16(5):341-6. PubMed ID: 7505194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal approaches to breast cancer treatment and prevention: an overview.
    Vogel CL
    Semin Oncol; 1996 Aug; 23(4 Suppl 9):2-9. PubMed ID: 8824459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
    Powles TJ
    J Natl Cancer Inst; 1999 Apr; 91(8):730. PubMed ID: 10218518
    [No Abstract]   [Full Text] [Related]  

  • 18. Patient reluctance toward tamoxifen use for breast cancer primary prevention.
    Port ER; Montgomery LL; Heerdt AS; Borgen PI
    Ann Surg Oncol; 2001 Aug; 8(7):580-5. PubMed ID: 11508619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Narod S
    J Natl Cancer Inst; 1999 Jan; 91(2):188. PubMed ID: 9923863
    [No Abstract]   [Full Text] [Related]  

  • 20. Tamoxifen's impact on the management of breast cancer: patient perspectives.
    Reichman BS
    Oncology (Williston Park); 1997 Feb; 11(2 Suppl 1):55-8. PubMed ID: 9065929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.